Wednesday, April 29, 2015

InCarda Therapeutics Finds $5M

San Francisco-based InCarda Therapeutics said Tuesday that it has raised $5M in a Series A funding, to go towards its therapies for acute cardiovascular conditions. The funding came from Morningside Ventures and angels. The company is developing drug delivery systems for trading cardiovascular conditions via inhaler. InCarda is led by Grace E. Colon, Ph.D. More information »